Information Provided By:
Fly News Breaks for April 17, 2017
ALR, ABT
Apr 17, 2017 | 07:54 EDT
Cowen analyst Joshua Jennings views the amended terms of Abbott's (ABT) deal with Alere (ALR) positively as it puts an end to controversial pre-closing saga and allows Abbot to become the leading point of care diagnostics provider. The amended deal lowered the takeover price and the closing will allow investors to focus now on the fundamentals of the combined entity. Jennings reiterated his Outperform rating and $48 price target on Abbot shares.
News For ABT;ALR From the Last 2 Days
There are no results for your query ABT;ALR